Integrating AI Models & Experimental Validation for De Novo Antibody & Biologic Design

  • Moving beyond selection toward design-first approaches for novel antibodies and biologics
  • Using AI-guided structural prediction to identify new binding sites and functional epitopes
  • Designing antibodies with targeted MOAs: activation, switching, signalling
  • Integrating AI models with experimental validation to accelerate biologic discovery pipelines